Johnson Winter & Slattery has advised Elanor Investors Group on its $123 million acquisition of two health and medical sector assets in Queensland from healthcare real estate investment trust NorthWest.
Elanor Investors Group is an ASX listed Australian real estate investment and funds management business with over $1.7 billion of assets across Australia and New Zealand.
The acquisitions seed Elanor Investors Group’s unlisted healthcare fund, which now comprises two multi-tenanted medical office and day surgeries at 55 Little Edward Street, Spring Hill, Brisbane and Pacific Private, 123 Nerang Street, Southport, Gold Coast.
The JWS team advising on the transaction was led by Real Estate Partner Peter Trevaskis, who worked alongside Senior Associate Stephanie Chun, and Associates Lucy Wang and Anna Shilova. Partner Andi Milidoni advised on the tax aspects of this transaction.
Peter Trevaskis said the firm was delighted to have supported Elanor on its strategic and timely investment.
“Elanor Investment Group is focused on securing assets that provide strong income and high quality capital growth potential for its funds management capital partners and Elanor security holders. With the current economic climate, investing in medical facilities is a strong strategy for the group, demonstrating its ability to show foresight and adapt quickly to market trends.”
-ENDS-
About Johnson Winter & Slattery
Johnson Winter & Slattery is an independent national Australian law firm with over 65 partners and offices across Australia. We advise major Australian and international corporations and investment funds on their most challenging transactions and disputes across Australia and surrounding regions. Working closely with clients, knowing their business, and appreciating their commercial objectives, we tailor our approach to deliver cost-effective commercial outcomes.
Media contacts:
Daya Knapton, Communications Manager
E: Daya.Knapton@jws.com.au
T: +61 2 8247 9638
Kate Potter, Business Development Director
E: Kate.Potter@jws.com.au
T: +61 2 8247 9659